Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Anaplastic Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00058123
What this trial is testing

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT00276770
What this trial is testing

Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
University of Washington 12
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Study completedNCT00045474
What this trial is testing

Brachytherapy in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00004113
What this trial is testing

Temozolomide in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT04541082
What this trial is testing

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Who this might be right for
Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more
Jazz Pharmaceuticals 102
Testing effectiveness (Phase 2)Ended earlyNCT01110876
What this trial is testing

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma Multiforme
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Ended earlyNCT01478321
What this trial is testing

Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+2 more
Northwestern University 54
Early research (Phase 1)Study completedNCT00002572
What this trial is testing

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
University of Colorado, Denver 10
Testing effectiveness (Phase 2)UnknownNCT00114309
What this trial is testing

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+3 more
TransMolecular 66
Early research (Phase 1)Study completedNCT00017264
What this trial is testing

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00079092
What this trial is testing

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Wake Forest University Health Sciences 18
Not applicableStudy completedNCT01004887
What this trial is testing

Study of Tissue and Blood Samples From Patients With High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 631
Not applicableStudy completedNCT00253487
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Children's Hospital Medical Center, Cincinnati
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Testing effectiveness (Phase 2)Study completedNCT00004868
What this trial is testing

SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT00036972
What this trial is testing

Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT02101905
What this trial is testing

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Oligodendroglioma+4 more
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT00006474
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Next Page